$RMD
RESMED INC

2020 Q4 Form 10-Q Financial Statement

#000094381921000002 Filed on January 29, 2021

View on sec.gov

Income Statement

Concept 2020 Q4 2019 Q4
Revenue $800.0M $736.2M
YoY Change 8.67% 13.06%
Cost Of Revenue $337.5M $309.0M
YoY Change 9.22% 11.74%
Gross Profit $462.5M $427.1M
YoY Change 8.28% 14.04%
Gross Profit Margin 57.81% 58.02%
Selling, General & Admin $169.5M $171.4M
YoY Change -1.14% 6.09%
% of Gross Profit 36.64% 40.13%
Research & Development $54.94M $49.94M
YoY Change 10.0% 15.85%
% of Gross Profit 11.88% 11.69%
Depreciation & Amortization $40.58M $39.12M
YoY Change 3.72% 8.37%
% of Gross Profit 8.77% 9.16%
Operating Expenses $240.8M $229.3M
YoY Change 4.99% 5.46%
Operating Profit $221.7M $197.8M
YoY Change 12.09% 25.93%
Interest Expense $5.792M $10.22M
YoY Change -43.33% 36.5%
% of Operating Profit 2.61% 5.17%
Other Income/Expense, Net -$11.12M -$19.06M
YoY Change -41.63% 76.37%
Pretax Income $210.6M $178.8M
YoY Change 17.81% 22.2%
Income Tax $31.08M $18.20M
% Of Pretax Income 14.76% 10.18%
Net Earnings $179.5M $160.6M
YoY Change 11.81% 28.82%
Net Earnings / Revenue 22.44% 21.81%
Basic Earnings Per Share $1.24 $1.11
Diluted Earnings Per Share $1.23 $1.10
COMMON SHARES
Basic Shares Outstanding 145.2M 144.2M
Diluted Shares Outstanding 146.4M 145.6M

Balance Sheet

Concept 2020 Q4 2019 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $255.9M $204.1M
YoY Change 25.38% 36.52%
Cash & Equivalents $255.9M $204.1M
Short-Term Investments
Other Short-Term Assets $202.0M $182.8M
YoY Change 10.5% 30.2%
Inventory $474.8M $377.8M
Prepaid Expenses
Receivables $509.4M $528.0M
Other Receivables $0.00 $0.00
Total Short-Term Assets $1.451B $1.300B
YoY Change 11.61% 22.28%
LONG-TERM ASSETS
Property, Plant & Equipment $459.5M $408.4M
YoY Change 12.52% 7.04%
Goodwill $1.910B $1.871B
YoY Change 2.13% 6.34%
Intangibles
YoY Change
Long-Term Investments $21.68M $54.70M
YoY Change -60.36% -12.98%
Other Assets $157.5M $163.9M
YoY Change -3.94% 18.72%
Total Long-Term Assets $3.121B $3.053B
YoY Change 2.22% 9.2%
TOTAL ASSETS
Total Short-Term Assets $1.451B $1.300B
Total Long-Term Assets $3.121B $3.053B
Total Assets $4.573B $4.354B
YoY Change 5.03% 12.8%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $122.2M $114.3M
YoY Change 6.86% 3.61%
Accrued Expenses $280.3M $217.8M
YoY Change 28.68% 13.72%
Deferred Revenue $105.2M $92.95M
YoY Change 13.22% 27.88%
Short-Term Debt $11.99M $11.98M
YoY Change 0.03% 0.05%
Long-Term Debt Due $12.00M $12.00M
YoY Change 0.0% 0.0%
Total Short-Term Liabilities $577.3M $500.0M
YoY Change 15.46% 14.57%
LONG-TERM LIABILITIES
Long-Term Debt $813.7M $1.288B
YoY Change -36.8% 8.6%
Other Long-Term Liabilities $9.481M $2.062M
YoY Change 359.8% -98.98%
Total Long-Term Liabilities $1.131B $1.596B
YoY Change -29.15% 8.75%
TOTAL LIABILITIES
Total Short-Term Liabilities $577.3M $500.0M
Total Long-Term Liabilities $1.131B $1.596B
Total Liabilities $1.708B $2.096B
YoY Change -18.51% 10.09%
SHAREHOLDERS EQUITY
Retained Earnings $3.077B $2.605B
YoY Change 18.11% 9.99%
Common Stock $1.574B $1.522B
YoY Change 3.43% 4.2%
Preferred Stock
YoY Change
Treasury Stock (at cost) $1.623B $1.623B
YoY Change 0.0% 0.0%
Treasury Stock Shares $41.84M $41.84M
Shareholders Equity $2.865B $2.258B
YoY Change
Total Liabilities & Shareholders Equity $4.573B $4.354B
YoY Change 5.03% 12.8%

Cashflow Statement

Concept 2020 Q4 2019 Q4
OPERATING ACTIVITIES
Net Income $179.5M $160.6M
YoY Change 11.81% 28.82%
Depreciation, Depletion And Amortization $40.58M $39.12M
YoY Change 3.72% 8.37%
Cash From Operating Activities $169.9M $69.90M
YoY Change 143.06% -46.02%
INVESTING ACTIVITIES
Capital Expenditures -$38.10M -$27.90M
YoY Change 36.56% 36.1%
Acquisitions
YoY Change
Other Investing Activities $8.400M -$15.70M
YoY Change -153.5% -97.54%
Cash From Investing Activities -$29.70M -$43.60M
YoY Change -31.88% -93.38%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -316.8M 800.0K
YoY Change -39700.0% -99.82%
NET CHANGE
Cash From Operating Activities 169.9M 69.90M
Cash From Investing Activities -29.70M -43.60M
Cash From Financing Activities -316.8M 800.0K
Net Change In Cash -176.6M 27.10M
YoY Change -751.66% -134.52%
FREE CASH FLOW
Cash From Operating Activities $169.9M $69.90M
Capital Expenditures -$38.10M -$27.90M
Free Cash Flow $208.0M $97.80M
YoY Change 112.68% -34.8%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Period End Date
DocumentPeriodEndDate
2020-12-31
dei Entity Address Country
EntityAddressCountry
US
dei Entity Central Index Key
EntityCentralIndexKey
0000943819
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q2 us-gaap Preferred Stock Value
PreferredStockValue
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-15317
dei Entity Registrant Name
EntityRegistrantName
ResMed Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-0152841
dei Entity Address Address Line1
EntityAddressAddressLine1
9001 Spectrum Center Blvd.
dei Entity Address City Or Town
EntityAddressCityOrTown
San Diego
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92123
dei City Area Code
CityAreaCode
858
dei Local Phone Number
LocalPhoneNumber
836-5000
dei Security12b Title
Security12bTitle
Common Stock, par value $0.004 per share
dei Trading Symbol
TradingSymbol
RMD
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
145509084
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
255865000
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
463156000
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
33593000
CY2020Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
28508000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
509364000
CY2020Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
474643000
CY2020Q4 us-gaap Inventory Net
InventoryNet
474821000
CY2020Q2 us-gaap Inventory Net
InventoryNet
416915000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
211435000
CY2020Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
168745000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
1451485000
CY2020Q2 us-gaap Assets Current
AssetsCurrent
1523459000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
459472000
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
417335000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
131291000
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
118348000
CY2020Q4 us-gaap Goodwill
Goodwill
1910492000
CY2020Q2 us-gaap Goodwill
Goodwill
1890324000
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
412998000
CY2020Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
448168000
CY2020Q4 us-gaap Deferred Income Taxes And Other Assets Noncurrent
DeferredIncomeTaxesAndOtherAssetsNoncurrent
49628000
CY2020Q2 us-gaap Deferred Income Taxes And Other Assets Noncurrent
DeferredIncomeTaxesAndOtherAssetsNoncurrent
41065000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
157490000
CY2020Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
148677000
CY2020Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
3121371000
CY2020Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
3063917000
CY2020Q4 us-gaap Assets
Assets
4572856000
CY2020Q2 us-gaap Assets
Assets
4587376000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
122166000
CY2020Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
135786000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
280332000
CY2020Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
270353000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
22445000
CY2020Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
21263000
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
105238000
CY2020Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
98617000
CY2020Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
35166000
CY2020Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
64755000
CY2020Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
11988000
CY2020Q2 us-gaap Short Term Borrowings
ShortTermBorrowings
11987000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
577335000
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
602761000
CY2020Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
86899000
CY2020Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
87307000
CY2020Q4 us-gaap Deferred Income Taxes And Other Tax Liabilities Noncurrent
DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent
12733000
CY2020Q2 us-gaap Deferred Income Taxes And Other Tax Liabilities Noncurrent
DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent
13011000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
117641000
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
101880000
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
9481000
CY2020Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
8347000
CY2020Q4 us-gaap Long Term Debt
LongTermDebt
813732000
CY2020Q2 us-gaap Long Term Debt
LongTermDebt
1164133000
CY2020Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
90051000
CY2020Q2 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
112910000
CY2020Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1130537000
CY2020Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1487588000
CY2020Q4 us-gaap Liabilities
Liabilities
1707872000
CY2020Q2 us-gaap Liabilities
Liabilities
2090349000
CY2020Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2020Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.004
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.004
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
350000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
350000000
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
187340332
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
145504098
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
186723407
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
144887175
us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
627668000
us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
572976000
CY2020Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
11164000
CY2019Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
12052000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
23143000
CY2020Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
582000
CY2020Q2 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
580000
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1574240000
CY2020Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1570694000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
3076569000
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2832991000
CY2020Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
41836234
CY2020Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
41836234
CY2020Q4 us-gaap Treasury Stock Value
TreasuryStockValue
1623256000
CY2020Q2 us-gaap Treasury Stock Value
TreasuryStockValue
1623256000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-163151000
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-283982000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
2864984000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
2497027000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4572856000
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4587376000
CY2020Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
800011000
CY2019Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
736157000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1551955000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1417213000
CY2020Q4 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
326364000
CY2019Q4 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
296975000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
25488000
CY2020Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
337528000
CY2019Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
309027000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
650811000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
598464000
CY2020Q4 us-gaap Gross Profit
GrossProfit
462483000
CY2019Q4 us-gaap Gross Profit
GrossProfit
427130000
us-gaap Gross Profit
GrossProfit
901144000
us-gaap Gross Profit
GrossProfit
818749000
CY2020Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
169470000
CY2019Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
171422000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
328459000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
338862000
CY2020Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
54935000
CY2019Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
49943000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
109468000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
97976000
CY2020Q4 rmd Amortization Of Acquired Intangible Assets1
AmortizationOfAcquiredIntangibleAssets1
7689000
CY2019Q4 rmd Amortization Of Acquired Intangible Assets1
AmortizationOfAcquiredIntangibleAssets1
8556000
rmd Amortization Of Acquired Intangible Assets1
AmortizationOfAcquiredIntangibleAssets1
15932000
rmd Amortization Of Acquired Intangible Assets1
AmortizationOfAcquiredIntangibleAssets1
13599000
CY2020Q4 us-gaap Restructuring Charges
RestructuringCharges
8673000
us-gaap Restructuring Charges
RestructuringCharges
8673000
CY2019Q4 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
-600000
us-gaap Litigation Settlement Expense
LitigationSettlementExpense
-600000
CY2020Q4 us-gaap Operating Expenses
OperatingExpenses
240767000
CY2019Q4 us-gaap Operating Expenses
OperatingExpenses
229321000
us-gaap Operating Expenses
OperatingExpenses
462532000
us-gaap Operating Expenses
OperatingExpenses
449837000
CY2020Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
221716000
CY2019Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
197809000
us-gaap Operating Income Loss
OperatingIncomeLoss
438612000
us-gaap Operating Income Loss
OperatingIncomeLoss
368912000
CY2020Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
132000
CY2019Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
202000
us-gaap Investment Income Interest
InvestmentIncomeInterest
249000
us-gaap Investment Income Interest
InvestmentIncomeInterest
650000
CY2020Q4 us-gaap Interest Expense
InterestExpense
5924000
CY2019Q4 us-gaap Interest Expense
InterestExpense
10220000
us-gaap Interest Expense
InterestExpense
12766000
us-gaap Interest Expense
InterestExpense
21212000
CY2020Q4 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-2640000
CY2019Q4 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-6924000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-4928000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-13786000
CY2020Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2692000
CY2019Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2115000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
5279000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-5225000
CY2020Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-11124000
CY2019Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-19057000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-12166000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-39573000
CY2020Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
210592000
CY2019Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
178752000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
426446000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
329339000
CY2020Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
31078000
CY2019Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18198000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
68560000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
48637000
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
179514000
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
160554000
us-gaap Net Income Loss
NetIncomeLoss
357886000
us-gaap Net Income Loss
NetIncomeLoss
280702000
CY2020Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.24
CY2019Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.11
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.47
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.95
CY2020Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.23
CY2019Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.10
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.45
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.93
CY2020Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.39
CY2019Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.39
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.78
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.78
CY2020Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
145246000
CY2019Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
144212000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
145053000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
143966000
CY2020Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
146421000
CY2019Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
145575000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
146350000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
145479000
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
179514000
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
160554000
us-gaap Net Income Loss
NetIncomeLoss
357886000
us-gaap Net Income Loss
NetIncomeLoss
280702000
CY2020Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
77040000
CY2019Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
44467000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
120831000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
6891000
CY2020Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
256554000
CY2019Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
205021000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
478717000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
287593000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
2497027000
CY2020Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1026000
CY2020Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
227000
CY2020Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
16071000
CY2019Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
6498000
CY2019Q4 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-40761000
CY2019Q4 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
12190000
CY2019Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
14057000
CY2019Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
44467000
CY2019Q4 us-gaap Dividends
Dividends
56150000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
2258106000
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
43791000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
178372000
CY2020Q3 us-gaap Dividends
Dividends
56511000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
2678860000
CY2020Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1857000
CY2020Q4 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-46732000
CY2020Q4 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
15729000
CY2020Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
15370000
CY2020Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
77040000
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
179514000
CY2020Q4 us-gaap Dividends
Dividends
56654000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
2864984000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
2072193000
CY2019Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
5609000
CY2019Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-327000
CY2019Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
13256000
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-37576000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
120148000
CY2019Q3 us-gaap Dividends
Dividends
56052000
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
2117251000
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
160554000
us-gaap Net Income Loss
NetIncomeLoss
357886000
us-gaap Net Income Loss
NetIncomeLoss
280702000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
80046000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
77077000
rmd Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
17911000
rmd Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
12323000
us-gaap Share Based Compensation
ShareBasedCompensation
31441000
us-gaap Share Based Compensation
ShareBasedCompensation
27309000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-4928000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-13786000
us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
-4776000
us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
5419000
us-gaap Restructuring Charges
RestructuringCharges
8673000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
500000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-7000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
19259000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
275000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
34212000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
28294000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
29875000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
66818000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-99348000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-88927000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
313915000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
232295000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
48443000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
47771000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
8367000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
4871000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
437000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
3423000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
14446000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
21841000
us-gaap Payments For Proceeds From Derivative Instrument Investing Activities
PaymentsForProceedsFromDerivativeInstrumentInvestingActivities
-19922000
us-gaap Payments For Proceeds From Derivative Instrument Investing Activities
PaymentsForProceedsFromDerivativeInstrumentInvestingActivities
-1064000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-51771000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-76842000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
18614000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
24297000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
-46507000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
-41091000
us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
302000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
55000000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
730000000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
406000000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
700012000
us-gaap Payments Of Dividends
PaymentsOfDividends
113165000
us-gaap Payments Of Dividends
PaymentsOfDividends
112202000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-492058000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-99310000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
22623000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
824000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-207291000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
56967000
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
463156000
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
147128000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
255865000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
204095000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
138247000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
141948000
us-gaap Interest Paid Net
InterestPaidNet
12766000
us-gaap Interest Paid Net
InterestPaidNet
21212000
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2020Q4 us-gaap Sales Type Lease Lease Income
SalesTypeLeaseLeaseIncome
1863000
CY2019Q4 us-gaap Sales Type Lease Lease Income
SalesTypeLeaseLeaseIncome
3068000
us-gaap Sales Type Lease Lease Income
SalesTypeLeaseLeaseIncome
3823000
us-gaap Sales Type Lease Lease Income
SalesTypeLeaseLeaseIncome
5326000
CY2020Q4 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
25026000
CY2019Q4 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
21317000
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
49805000
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
42952000
CY2020Q4 rmd Lessor Lease Revenue
LessorLeaseRevenue
26889000
CY2019Q4 rmd Lessor Lease Revenue
LessorLeaseRevenue
24385000
rmd Lessor Lease Revenue
LessorLeaseRevenue
53628000
rmd Lessor Lease Revenue
LessorLeaseRevenue
48278000
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2020Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
800011000
CY2019Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
736157000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1551955000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1417213000
CY2020Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
40580000
CY2019Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
39123000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
80046000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
77077000
CY2019Q4 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
-600000
us-gaap Litigation Settlement Expense
LitigationSettlementExpense
-600000
CY2020Q4 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
0.0
us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
2800000
CY2020Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
153427000
CY2020Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
128096000
CY2020Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
2439000
CY2020Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
2807000
CY2020Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
318955000
CY2020Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
286012000
CY2020Q4 us-gaap Inventory Net
InventoryNet
474821000
CY2020Q2 us-gaap Inventory Net
InventoryNet
416915000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1060896000
CY2020Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
969166000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
601424000
CY2020Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
551831000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
459472000
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
417335000
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
412998000
CY2020Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
448168000
CY2020Q2 us-gaap Goodwill
Goodwill
1890324000
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
20168000
CY2020Q4 us-gaap Goodwill
Goodwill
1910492000
CY2020Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
145246000
CY2019Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
144212000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
145053000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
143966000
CY2020Q4 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1175000
CY2019Q4 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1363000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1297000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.47
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.95
CY2020Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.23
CY2020Q4 rmd Marketable Equity Investments Fair Value
MarketableEquityInvestmentsFairValue
15345000
CY2020Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
21410000
CY2020Q2 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
30033000
CY2020Q4 us-gaap Equity Method Investments
EquityMethodInvestments
21681000
CY2020Q2 us-gaap Equity Method Investments
EquityMethodInvestments
14109000
CY2020Q4 rmd Equity Investments Total By Measurement Category
EquityInvestmentsTotalByMeasurementCategory
58436000
CY2020Q2 rmd Equity Investments Total By Measurement Category
EquityInvestmentsTotalByMeasurementCategory
44142000
CY2020Q4 us-gaap Marketable Securities Unrealized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments
-3700000
us-gaap Marketable Securities Unrealized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments
4800000
CY2019Q4 us-gaap Marketable Securities Unrealized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments
-2800000
us-gaap Marketable Securities Unrealized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments
-5400000
CY2020Q4 us-gaap Long Term Debt
LongTermDebt
813732000
CY2020Q2 us-gaap Long Term Debt
LongTermDebt
1164133000
CY2020Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
825720000
CY2020Q2 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
1176120000
rmd Debt To Consolidated Ebitda Ratio
DebtToConsolidatedEbitdaRatio
3.50
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1513000
CY2020Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
146421000
CY2019Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
145575000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
146350000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
145479000
CY2020Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.24
CY2019Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.11
CY2020Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
21132000
CY2019Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
19625000
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
8309000
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
6776000
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
7075000
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
6191000
us-gaap Standard And Extended Product Warranty Accrual Foreign Currency Translation Gain Loss
StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss
-1903000
us-gaap Standard And Extended Product Warranty Accrual Foreign Currency Translation Gain Loss
StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss
-76000
CY2020Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
24269000
CY2019Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
20286000
CY2020Q4 rmd Short Term Borrowings Gross
ShortTermBorrowingsGross
12000000
CY2020Q2 rmd Short Term Borrowings Gross
ShortTermBorrowingsGross
12000000
CY2020Q4 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
12000
CY2020Q2 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
13000
CY2020Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
11988000
CY2020Q2 us-gaap Short Term Borrowings
ShortTermBorrowings
11987000
CY2020Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
817000000
CY2020Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1168000000
CY2020Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
3268000
CY2020Q2 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
3867000
CY2020Q4 us-gaap Senior Notes
SeniorNotes
500000000.0
CY2020Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
196856000
CY2019Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
73509000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
154888000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
88624000
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
179514000
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
160554000
us-gaap Net Income Loss
NetIncomeLoss
357886000
us-gaap Net Income Loss
NetIncomeLoss
280702000
CY2019Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.10
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.45
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.93
CY2020Q4 us-gaap Restructuring Reserve Noncurrent
RestructuringReserveNoncurrent
2600000

Files In Submission

Name View Source Status
0000943819-21-000002-index-headers.html Edgar Link pending
0000943819-21-000002-index.html Edgar Link pending
0000943819-21-000002.txt Edgar Link pending
0000943819-21-000002-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rmd-20201231.xsd Edgar Link pending
rmd-20201231x10q.htm Edgar Link pending
rmd-20201231x10q_htm.xml Edgar Link completed
rmd-20201231xex31_1.htm Edgar Link pending
rmd-20201231xex31_2.htm Edgar Link pending
rmd-20201231xex32.htm Edgar Link pending
rmd-20201231_cal.xml Edgar Link unprocessable
rmd-20201231_def.xml Edgar Link unprocessable
rmd-20201231_lab.xml Edgar Link unprocessable
rmd-20201231_pre.xml Edgar Link unprocessable
Show.js Edgar Link pending